Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026)
Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 349.70 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 1.12 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | -207.22 Mn |
| 10 | Nexalin Technology | 9.22 Mn | 6.52 Mn | 13,133.00 | 792,797.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 792,797.00 |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 779,900.00 |
| Jun 30, 2025 | 687,012.00 |
| Mar 31, 2025 | 929,220.00 |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 598,757.00 |
| Mar 31, 2024 | 483,313.00 |
| Dec 31, 2023 | -872,610.00 |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 479,545.00 |
| Mar 31, 2023 | 344,953.00 |
| Dec 31, 2022 | 407,930.00 |
| Sep 30, 2022 | 479,445.00 |
| Jun 30, 2022 | 385,990.00 |
| Mar 31, 2022 | 218,374.00 |
| Dec 31, 2021 | 296,093.00 |
| Sep 30, 2021 | 1.62 Mn |